Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Sonata (zaleplon) CIV Capsules, Wyeth-Ayerst NDA 20-859/S2 & S3 5/31/02 6/3/02 Sonata (zaleplon) Capsule, 5 mg & 10 mg, Wyeth-Ayerst NDA 20-859/S1 2/22/01 3/5/01 3/5/01 Sonata (zaleplon) Capsule, Wyeth-Ayerst NDA 20-859 8/13/99 3/21/00 3/21/00 7/3/00 Sonata Indications: short-term treatment of insomnia ZALEPLON Capsule; 10MG SONATA JONES 020859 ZALEPLON Capsule; 5MG SONATA JONES | Zaleplon Capsules, Roxane Labs, Tentative Approval | Zaleplon Capsules, Teva Pharma, Tentative Approval | Zaleplon Capsules, Genpharm, Tentative Approval | Sonata (zaleplon) Capsules, King Pharma, Labeling Revision | Zaleplon Capsules, Roxane Laboratories, Inc., Approval | Zaleplon Capsules, Genpharm ULC, Approval | Zaleplon Capsules, Sandoz, Inc., Approval | Zaleplon Capsules, Upsher-Smith Laboratories, Inc., Approval | Zaleplon Capsules, Aurobindo Pharma USA, Inc., Approval | Zaleplon Capsules, Unichem Pharmaceuticals USA, Inc., Approval | Zaleplon Capsules, Teva Pharmaceuticals USA, Approval | Zaleplon Capsules, Cipla, Ltd., Approval | Zaleplon Capsules, West-ward Pharmaceutical Corp., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com